ECSP993104A - NEW ORAL FORMULATION - Google Patents

NEW ORAL FORMULATION

Info

Publication number
ECSP993104A
ECSP993104A ECSP993104A ECSP993104A EC SP993104 A ECSP993104 A EC SP993104A EC SP993104 A ECSP993104 A EC SP993104A EC SP993104 A ECSP993104 A EC SP993104A
Authority
EC
Ecuador
Prior art keywords
oral formulation
new oral
composition
new
active agents
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Christian Vitzling
Gunter Engel
Bruijn Karel De
Hans-Jurgen Pfannkuche
Michael Thewissen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993104 priority Critical patent/ECSP993104A/en
Publication of ECSP993104A publication Critical patent/ECSP993104A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica, en particular a una composición para administrar agentes activos que son pobremente solubles en medios acuosos, y/o que son sensibles al ácido.The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents that are poorly soluble in aqueous media, and / or that are acid sensitive.

ECSP993104 1999-08-18 1999-08-18 NEW ORAL FORMULATION ECSP993104A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993104 ECSP993104A (en) 1999-08-18 1999-08-18 NEW ORAL FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993104 ECSP993104A (en) 1999-08-18 1999-08-18 NEW ORAL FORMULATION

Publications (1)

Publication Number Publication Date
ECSP993104A true ECSP993104A (en) 1999-10-06

Family

ID=42044091

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993104 ECSP993104A (en) 1999-08-18 1999-08-18 NEW ORAL FORMULATION

Country Status (1)

Country Link
EC (1) ECSP993104A (en)

Similar Documents

Publication Publication Date Title
YU8701A (en) New oral formulation
DK1183014T3 (en) Flavored controlled release oral pharmaceutical compositions
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
NO20011471D0 (en) New oral sustained release formulations
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
CY1111698T1 (en) COMBINATION INCLUDING AN AT1 COMPETITIVE RECEPTOR AND AN INSULIN EXTRACTOR OR A INSULIN SENSITIVE
ATE541562T1 (en) IBUPROFEN SUSPENSION
DE50005529D1 (en) ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
HRP20010684B1 (en) DIRECTLY STLACITIC MATRIX FOR CONTROLLED RELEASE OF A SINGLE-DAILY DOSE OF CLARITROMYCIN
AR031649A1 (en) DRONEDARONA PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION
SE0001916D0 (en) Novel formulation
TR200103151T2 (en) A pharmaceutical formulation containing a carboxypeptidase U inhibitor and a thrombin inhibitor.
DE60004204D1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF
CR6300A (en) NEW ORAL FORMULATION
SE9902742D0 (en) New pharmaceutical formultion
MY152490A (en) New oral formulation
DE60112578D1 (en) PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE